GW Pharmaceuticals pioneered the use of cannabis-derived medicines, most notably . Since the acquisition, this platform has become a cornerstone of the Jazz Pharmaceuticals business model.
: By acquiring GW, Jazz Pharmaceuticals significantly reduced its reliance on its flagship narcolepsy drug, Xyrem . The combined company now has a robust portfolio across neuroscience and oncology. buy stock in gw pharmaceuticals
Investment Rationale for GW Pharmaceuticals (via Jazz Pharmaceuticals) most notably . Since the acquisition